
pmid: 8384010
A 69-year-old man who had been taking digoxin for 2.5 years developed an elevated serum concentration of digoxin in association with digoxin toxicity (characterized by nausea and vomiting) 9 days after the addition of itraconazole to his regimen for the treatment of sternal osteomyelitis. Coadministration of itraconazole resulted in a statistically significant increase in the half-life of digoxin that necessitated a reduction of the digoxin dose by almost 60%. We thus recommend that patients receiving itraconazole and digoxin concomitantly have serum levels of digoxin monitored frequently. In addition, these patients should be carefully questioned about nonspecific gastrointestinal symptoms, which may indicate early digoxin toxicity.
Male, Digoxin, Antifungal Agents, Aspergillus fumigatus, Osteomyelitis, Ketoconazole, Aspergillosis, Humans, Drug Interactions, Itraconazole, Least-Squares Analysis, Aged, Half-Life
Male, Digoxin, Antifungal Agents, Aspergillus fumigatus, Osteomyelitis, Ketoconazole, Aspergillosis, Humans, Drug Interactions, Itraconazole, Least-Squares Analysis, Aged, Half-Life
| citations This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 68 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Average | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Top 10% | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Top 10% |
